MiNK Therapeutics, Inc.(INKT)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | Ryan Barbara Director | Sale | -1,500 | -6.39%21,969 | $12.76 | $19,141 | View SEC filing | |
| 2026-03-11 | Ryan Barbara Director | Sale | -1,500 | -6.85%20,406 | $14.70 | $22,052 | View SEC filing | |
| 2026-03-04 | Ryan Barbara Director | Sale | -500 | -2.23%21,906 | $10.85 | $5,426 | View SEC filing | |
| 2023-10-16 | AGENUS INC 10% Owner | Purchase | +22,975 | +0.11%21,772,863 | $1.10 | $25,270 | View SEC filing | |
| 2023-10-06 | AGENUS INC 10% Owner | Purchase | +15,001 | +0.07%21,749,888 | $1.09 | $16,380 | View SEC filing | |
| 2023-08-31 | AGENUS INC 10% Owner | Purchase | +29,678 | +0.14%21,734,887 | $1.52 | $45,016 | View SEC filing | |
| 2023-08-28 | AGENUS INC 10% Owner | Purchase | +183,052 | +0.85%21,705,209 | $1.54 | $281,478 | View SEC filing | |
| 2023-05-12 | AGENUS INC 10% Owner | Purchase | +45,426 | +0.21%21,640,473 | $1.47 | $66,644 | View SEC filing | |
| 2023-05-05 | ARMEN GARO H Director | Sale | -100,000 | -5.09%1,866,400 | $0.95 | $94,850 | View SEC filing | |
| 2023-05-05 | AGENUS INC 10% Owner | Purchase | +250,362 | +1.17%21,595,047 | $1.04 | $260,189 | View SEC filing | |
| 2023-05-04 | ARMEN GARO H Director | Purchase | +100,000 | +5.32%1,978,010 | $0.95 | $94,850 | View SEC filing | |
| 2022-07-21 | WIINBERG ULF Director | Purchase | +20,000 | +7.19%298,300 | $1.38 | $27,646 | View SEC filing | |
| 2021-10-20 | AGENUS INC 10% Owner | Purchase | +1,400,000 | +7.19%20,881,000 | $12.00 | $16,800,000 | View SEC filing |
1-13 of 13